Literature DB >> 21998110

Transarterial treatment with Onyx of intracranial dural arteriovenous fistula with cortical drainage in 17 patients.

S Maimon1, E Nossek, I Strauss, D Blumenthal, V Frolov, Z Ram.   

Abstract

BACKGROUND AND
PURPOSE: Intracranial DAVFs with cortical venous drainage have a high tendency to bleed. Complete closure of these lesions is essential to prevent clinically deleterious events. We describe our experience using Onyx in an arterial approach for treatment of DAVFs in 17 patients.
MATERIALS AND METHODS: Between 2006 and 2010, we used Onyx for performing transarterial embolization in 17 patients with intracranial DAVFs and cortical venous drainage. Clinical assessment was performed before and after every treatment at discharge and at follow-up. Fourteen patients underwent follow-up MR imaging and MRA, 8 of them also underwent follow-up diagnostic angiography.
RESULTS: Fifteen patients (88%) underwent 1 procedure. Complete obliteration by embolization with Onyx was achieved in 16 patients (94% acute obliteration). The mean amount of Onyx injected was 2.3 mL (range, 0.4-4.8 mL). The sole technical complication was an embolus to a branch of the MCA, which was resolved by intra-arterial tPA injection. A clinical complication of transient trochlear nerve palsy in the same patient due to mass effect of Onyx resolved spontaneously within 3 months.
CONCLUSIONS: Intra-arterial embolization of cranial DAVFs with cortical venous drainage by using Onyx results in a high rate of complete obliteration (94%) with low morbidity (6%). Follow-up DSA in 8 patients revealed no evidence of reopening.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21998110      PMCID: PMC7964375          DOI: 10.3174/ajnr.A2728

Source DB:  PubMed          Journal:  AJNR Am J Neuroradiol        ISSN: 0195-6108            Impact factor:   3.825


  14 in total

1.  Transvenous treatment of spontaneous dural carotid-cavernous fistulas using a combination of detachable coils and Onyx.

Authors:  S Suzuki; D W Lee; R Jahan; G R Duckwiler; F Viñuela
Journal:  AJNR Am J Neuroradiol       Date:  2006 Jun-Jul       Impact factor: 3.825

2.  [Transarterial embolisation of intracranial dural arteriovenous malformations with ethylene vinyl alcohol copolymer (Onyx18)].

Authors:  F Toulgoat; C Mounayer; M Túlio Salles Rezende; M Piotin; L Spelle; G Lazzarotti; H Desal; J Moret
Journal:  J Neuroradiol       Date:  2006-04       Impact factor: 3.447

3.  Brain AVM embolization with Onyx.

Authors:  W J van Rooij; M Sluzewski; G N Beute
Journal:  AJNR Am J Neuroradiol       Date:  2007-01       Impact factor: 3.825

4.  Dural arteriovenous fistula of the lesser sphenoid wing region treated with Onyx: technical note.

Authors:  Marco Túlio Salles Rezende; Michel Piotin; Charbel Mounayer; Laurent Spelle; Daniel Giansante Abud; Jacques Moret
Journal:  Neuroradiology       Date:  2006-01-21       Impact factor: 2.804

5.  Brain arteriovenous malformation treatment using a combination of Onyx and a new detachable tip microcatheter, SONIC: short-term results.

Authors:  S Maimon; I Strauss; V Frolov; N Margalit; Z Ram
Journal:  AJNR Am J Neuroradiol       Date:  2010-02-25       Impact factor: 3.825

6.  Nidal embolization of brain arteriovenous malformations using Onyx in 94 patients.

Authors:  C Mounayer; N Hammami; M Piotin; L Spelle; G Benndorf; I Kessler; J Moret
Journal:  AJNR Am J Neuroradiol       Date:  2007-03       Impact factor: 3.825

7.  Endovascular treatment of intracranial dural arteriovenous fistulas with cortical venous drainage: new management using Onyx.

Authors:  C Cognard; A C Januel; N A Silva; P Tall
Journal:  AJNR Am J Neuroradiol       Date:  2007-11-07       Impact factor: 3.825

8.  Treatment of dural arteriovenous fistula using ethylene vinyl alcohol (onyx) arterial embolization as the primary modality: short-term results.

Authors:  Andrew P Carlson; Christopher L Taylor; Howard Yonas
Journal:  J Neurosurg       Date:  2007-12       Impact factor: 5.115

9.  A proposed classification for spinal and cranial dural arteriovenous fistulous malformations and implications for treatment.

Authors:  J A Borden; J K Wu; W A Shucart
Journal:  J Neurosurg       Date:  1995-02       Impact factor: 5.115

10.  Preliminary experience with onyx embolization for the treatment of intracranial dural arteriovenous fistulas.

Authors:  R G Nogueira; G Dabus; J D Rabinov; C J Eskey; C S Ogilvy; J A Hirsch; J C Pryor
Journal:  AJNR Am J Neuroradiol       Date:  2007-11-01       Impact factor: 3.825

View more
  6 in total

1.  Recurrence of "cured" dural arteriovenous fistulas after Onyx embolization.

Authors:  Peter Adamczyk; Arun Paul Amar; William J Mack; Donald W Larsen
Journal:  Neurosurg Focus       Date:  2012-05       Impact factor: 4.047

2.  A hemorrhagic complication after Onyx embolization of a tentorial dural arteriovenous fistula: A caution about subdural extension with pial arterial supply.

Authors:  Kenichi Sato; Yasushi Matsumoto; Hidenori Endo; Teiji Tominaga
Journal:  Interv Neuroradiol       Date:  2017-01-01       Impact factor: 1.610

3.  Posterior Fossa Dural Arteriovenous Fistulas with Subarachnoid Venous Drainage: Outcomes of Endovascular Treatment.

Authors:  L Détraz; K Orlov; V Berestov; V Borodetsky; A Rouchaud; L G de Abreu Mattos; C Mounayer
Journal:  AJNR Am J Neuroradiol       Date:  2019-08-01       Impact factor: 3.825

4.  Onyx versus nBCA and coils in the treatment of intracranial dural arteriovenous fistulas.

Authors:  Douglas M Choo; Jai Jai Shiva Shankar
Journal:  Interv Neuroradiol       Date:  2016-01-08       Impact factor: 1.610

5.  Treatment of cranial dural arteriovenous fistulas with exclusive cortical venous drainage: A single-center cohort of 35 patients.

Authors:  H G Kortman; G Bloemsma; I Boukrab; J P Peluso; M Sluzewski; B van der Pol; G N Beute; C B Majoie; W J van Rooij
Journal:  Interv Neuroradiol       Date:  2017-10-04       Impact factor: 1.610

6.  Efficacy and limitations of transarterial acrylic glue embolization for intracranial dural arteriovenous fistulas.

Authors:  Naoko Miyamoto; Isao Naito; Tatsuya Shimizu; Yuhei Yoshimoto
Journal:  Neurol Med Chir (Tokyo)       Date:  2015-01-23       Impact factor: 1.742

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.